NPRA In Malaysia Has Broadened Reference Approval Guidelines
The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that...
Pharmaceutical Packaging – Finding Its Way Beyond Borders
According to a study that was conducted by Grand View Research 1, the global pharmaceutical packaging market is all set to grow at a...
New Pharma Legislation May Affect Europe R&D Significantly
The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a...
Vetter In Rankweil Gets Permanent Manufacturer Authorization
Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in...
Global Healthcare Access Improved By Indian Pharma Cos.
As per Indian Government Union Minister Bhagwanth Khuba, Indian pharmaceutical companies have gone on to emerge as dependable and cost-effective options when it comes...
Biden Designates 31 Tech Hubs, With 10 For Pharma, Biotech
Traditionally, the tech as well as the biotech sectors across the US have been existing in a handful of regions, such as Silicon Valley....
Unlocking The Possibilities of Point-of-Care Manufacturing
It is well to be noted that biopharma production in today’s times takes place in the centralised manufacturing setups. Industry as well as regulators...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...